Company SynCore Biotechnology Co.,Ltd

Equities

4192

TW0004192000

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 18:00:00 2024-05-14 EDT 5-day change 1st Jan Change
46 TWD +0.88% Intraday chart for SynCore Biotechnology Co.,Ltd -1.39% +19.79%

Business Summary

SynCore Biotechnology Co.,Ltd is a Taiwan-based company principally engaged in the research, development, production and sales of therapeutic drugs. The Company's main product is SB03 Veregen. The Company is also involved in research, development and clinical trials of the injection-type anticancer drug, SB01 and the oral anticancer drug, SB01. The Company distributes its products mainly in domestic market.

Number of employees: 40

Sales per Business

TWD in Million2022Weight2023Weight Delta
Functional Food
51.0 %
7 46.3 % 10 51.0 % +40.47%
Therapeutic Medication
49.0 %
9 53.7 % 10 49.0 % +16.08%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
16 100.0 % 20 100.0 % +27.36%

Managers

Managers TitleAgeSince
Chief Executive Officer - 08-06-08
Director of Finance/CFO - 13-05-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 13-11-26
Founder - 08-06-25
Chief Executive Officer - 08-06-08
Director/Board Member - 08-06-08
Director/Board Member - 13-11-26
Director/Board Member - 13-06-02
Director/Board Member - 13-11-26
Director/Board Member - 22-05-25
Director/Board Member - 13-11-26
Director/Board Member - 18-07-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 35,165,000 10,796,500 ( 30.70 %) 0 30.70 %

Company contact information

SynCore Biotechnology Co., Ltd.

No. 84, Zhongshan Road Zhongshan Village

269, Yilan

+886 3 958 6101

http://www.syncorebio.com
address SynCore Biotechnology Co.,Ltd(4192)
  1. Stock Market
  2. Equities
  3. 4192 Stock
  4. Company SynCore Biotechnology Co.,Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW